H.R. 4110 · 117th Congress · House

Reducing Hereditary Cancer Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Jun 23, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Reducing Hereditary Cancer Act of 2021

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Action Timeline

6
  1. JUN 24, 2021•Committee

    Referred to the Subcommittee on Health.

  2. JUN 23, 2021•IntroReferral

    Introduced in House

  3. JUN 23, 2021•IntroReferral

    Introduced in House

  4. JUN 23, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. JUN 23, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. JUN 23, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

4

Health Subcommittee

hsif14

Referred: Jun 24, 2021

Active

Health Subcommittee

hswm02

Referred: Jun 23, 2021

Active

Ways and Means Committee

hswm00

Referred: Jun 23, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jun 23, 2021

Active